Mereo BioPharma Group Statistics

Total Valuation

MREO has a market cap or net worth of $544.25 million. The enterprise value is $489.18 million.

Market Cap	544.25M
Enterprise Value	489.18M

Important Dates

The next estimated earnings date is Thursday, September 5, 2024, before market open.

Earnings Date	Sep 5, 2024
Ex-Dividend Date	n/a

Share Statistics

MREO has 140.27 million shares outstanding.

Shares Outstanding	140.27M
Owned by Insiders (%)	0.55%
Owned by Institutions (%)	58.10%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	9.84
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.86, with a Debt / Equity ratio of 0.14.

Current Ratio	4.86
Quick Ratio	n/a
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +212.90% in the last 52 weeks. The beta is 0.89, so MREO's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	+212.90%
50-Day Moving Average	3.55
200-Day Moving Average	2.92
Relative Strength Index (RSI)	54.52
Average Volume (20 Days)	977,516

Short Selling Information

Short Interest	2.92M
Short Previous Month	2.35M
Short % of Shares Out	2.27%
Short % of Float	n/a
Short Ratio (days to cover)	1.81

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	n/a
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	-$0.15

Full Income Statement

Balance Sheet

The company has $62.84 million in cash and $7.77 million in debt, giving a net cash position of $55.06 million or $0.39 per share.

Cash & Cash Equivalents	62.84M
Total Debt	7.77M
Net Cash	55.06M
Net Cash Per Share	$0.39
Equity (Book Value)	55.32M
Book Value Per Share	0.39
Working Capital	54.87M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MREO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.09%
Shareholder Yield	-16.09%
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

The average price target for MREO is $7.50, which is 93.30% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.50
Price Target Difference	93.30%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	60.72%
EPS Growth Forecast (5Y)	-30.45%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2